Back to Search
Start Over
Inovio announces positive interim phase 1 data for INO-4800 vaccine for COVID-19
- Source :
- PharmaBiz. July 1, 2020
- Publication Year :
- 2020
-
Abstract
- Inovio, a biotechnology company, announced positive interim clinical data of INO-4800, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the first two phase 1 clinical trial cohorts. In addition, INO-4800 [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- PharmaBiz
- Publication Type :
- Periodical
- Accession number :
- edsgcl.628199160